2-(1H-Benzo[d][1,2,3]triazol-1-yl)-2-(((benzyloxy)carbonyl)amino)acetic acid, 95.0%, 500mg

(S)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionic acid, 98.0%, 1g

Imidazol, min. 99 %, 1 kg, kunststoffverpackung.

Planphase PLPHi 20x/0,40 unendlich korrigiertes IOS-Objektiv. Arbeitsabstand 8,80 mm

1-(Ethoxycarbonyl)imidazo[1,5-a]pyridine-6-carboxylic acid hydrochloride, 98%, 100mg

3-Bromo-6-methoxy-1H-pyrrolo[3,2-b]pyridine, 97.0%, 1g

(S)-3-((tert-Butoxycarbonyl)amino)-6-methoxy-6-oxohexanoic acid, 97%, 1g

2-Amino-4,6-dichloro-5-methylpyrimidine, 95.0%, 1g

ethyl trans-4-cyclopropylpyrrolidine-3-carboxylate hydrochloride, 97.0%, 250mg

1-Piperidinecarboxylic acid, 4-(4-bromophenyl)-4-fluoro-, 1,1-dimethylethyl ester, 95.0%, 250mg

2-Thiophenesulfinic acid sodium salt, 97%, 5g

5-Chloro-3-[2-(5-chloro-2-methylthien-3-yl)cyclopent-1-en-1-yl]-2-methylthiophene, 95.0%, 100mg

6-hydroxy-5-nitro-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98%, 5g